Jerome Santoro

738 total citations
25 papers, 485 citations indexed

About

Jerome Santoro is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jerome Santoro has authored 25 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Jerome Santoro's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Poisoning and overdose treatments (3 papers). Jerome Santoro is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Poisoning and overdose treatments (3 papers). Jerome Santoro collaborates with scholars based in United States. Jerome Santoro's co-authors include Matthew E. Levison, Mark J. Ingerman, Donald Kaye, Lawrence L. Livornese, Robert L. Benz, Jaime Carrizosa, I. Bruce Elfenbein, Oksana M. Korzeniowski, P Weiner and Deborah R. Kaye and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Jerome Santoro

24 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome Santoro United States 12 198 186 161 89 73 25 485
W. John Spicer Australia 13 112 0.6× 145 0.8× 107 0.7× 63 0.7× 70 1.0× 34 469
Mark J. Ingerman United States 9 146 0.7× 191 1.0× 106 0.7× 110 1.2× 117 1.6× 10 357
Ronica M. Kluge United States 12 123 0.6× 146 0.8× 193 1.2× 58 0.7× 145 2.0× 20 544
A. M. Lovering United Kingdom 13 216 1.1× 249 1.3× 168 1.0× 98 1.1× 79 1.1× 26 611
G. K. Daikos Greece 16 252 1.3× 140 0.8× 209 1.3× 70 0.8× 175 2.4× 63 648
John L. Brusch United States 12 175 0.9× 219 1.2× 299 1.9× 83 0.9× 90 1.2× 23 659
Jacques Dubois Canada 13 119 0.6× 91 0.5× 225 1.4× 64 0.7× 127 1.7× 27 447
Maria Iris Cassetta Italy 14 330 1.7× 259 1.4× 245 1.5× 96 1.1× 154 2.1× 32 709
Pejman Dehghanyar Austria 11 326 1.6× 146 0.8× 119 0.7× 99 1.1× 87 1.2× 11 525
W D Kobasa United States 12 129 0.7× 144 0.8× 350 2.2× 97 1.1× 91 1.2× 22 585

Countries citing papers authored by Jerome Santoro

Since Specialization
Citations

This map shows the geographic impact of Jerome Santoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Santoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Santoro more than expected).

Fields of papers citing papers by Jerome Santoro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Santoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Santoro. The network helps show where Jerome Santoro may publish in the future.

Co-authorship network of co-authors of Jerome Santoro

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Santoro. A scholar is included among the top collaborators of Jerome Santoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Santoro. Jerome Santoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tayyar, Ralph, et al.. (2021). Immune Reconstitution Inflammatory Syndrome in Mycobacterium chimaera Mediastinitis. International Journal of Mycobacteriology. 10(1). 82–84.
2.
Santoro, Jerome, et al.. (2012). Ritonavir and Epidural Triamcinolone as a Cause of Iatrogenic Cushing’s Syndrome. The American Journal of the Medical Sciences. 344(1). 72–74. 25 indexed citations
3.
Bruminhent, Jackrapong, et al.. (2012). Listeria monocytogenes Cholecystitis: A Possible New Syndrome. The American Journal of the Medical Sciences. 345(5). 414–417. 8 indexed citations
4.
Santoro, Jerome, et al.. (2012). Clostridium septicum growth from a total knee arthroplasty associated with intestinal malignancy: a case report. BMC Infectious Diseases. 12(1). 235–235. 8 indexed citations
5.
Santoro, Jerome, et al.. (2011). Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis. Clinical and Experimental Nephrology. 16(2). 320–324. 28 indexed citations
6.
Sae-Tia, Sutthichai, et al.. (2009). Mycobacterium avium-avium-Associated Typhlitis Mimicking Appendicitis in an Immunocompetent Host. The American Journal of the Medical Sciences. 337(3). 218–220. 1 indexed citations
7.
Sharma, Madhulika, et al.. (2007). Disseminated Nocardia Otitidiscaviarum Infection in a Woman with Sickle Cell Anemia and End-Stage Renal Disease. The American Journal of the Medical Sciences. 333(6). 372–375. 8 indexed citations
8.
Livornese, Lawrence L., et al.. (2004). Use of antibacterial agents in renal failure. Infectious Disease Clinics of North America. 18(3). 551–579. 21 indexed citations
9.
Livornese, Lawrence L., et al.. (2001). USE OF ANTIBACTERIAL AGENTS IN RENAL FAILURE. Infectious Disease Clinics of North America. 15(3). 983–1002. 6 indexed citations
10.
Livornese, Lawrence L., et al.. (2000). USE OF ANTIBACTERIAL AGENTS IN RENAL FAILURE. Infectious Disease Clinics of North America. 14(2). 371–390. 32 indexed citations
11.
Ingerman, Mark J. & Jerome Santoro. (1989). Vancomycin. A new old agent.. PubMed. 3(3). 641–51. 30 indexed citations
12.
Santoro, Jerome, et al.. (1988). Lymphocutaneous nocardiosis in Pennsylvania.. PubMed. 91(11). 54, 56, 58–54, 56, 58. 5 indexed citations
13.
Ingerman, Mark J., P Weiner, Jerome Santoro, et al.. (1987). Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.. PubMed. 82(4A). 262–5. 48 indexed citations
14.
Sugar, Alan M., Peter D. Utsinger, & Jerome Santoro. (1982). Case Report Gonococcal Endocarditis in a Patient with Mitral Valve Prolapse: Study of Host Immunology and Organism Characteristics. The American Journal of the Medical Sciences. 283(3). 165–168. 7 indexed citations
15.
Santoro, Jerome, et al.. (1979). In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55 Suppl 4. 12–6. 6 indexed citations
16.
Santoro, Jerome & Matthew E. Levison. (1978). Rat model of experimental endocarditis. Infection and Immunity. 19(3). 915–918. 88 indexed citations
17.
Santoro, Jerome & Donald Kaye. (1978). Recurrent Urinary Tract Infections: Pathogenesis and Management. Medical Clinics of North America. 62(5). 1005–1020. 10 indexed citations
18.
Parsons, James L., et al.. (1978). Pharmacology and Efficacy of Netilmicin. Antimicrobial Agents and Chemotherapy. 13(5). 832–836. 23 indexed citations
19.
Carrizosa, Jaime, Jerome Santoro, & Donald Kaye. (1978). Treatment of Experimental Staphylococcus aureus Endocarditis: Comparison of Cephalothin, Cefazolin, and Methicillin. Antimicrobial Agents and Chemotherapy. 13(1). 74–77. 29 indexed citations
20.
Levison, Matthew E., et al.. (1977). In Vitro Activity and Clinical Efficacy of Clindamycin in the Treatment of Infections Due to Anaerobic Bacteria. The Journal of Infectious Diseases. 135(Supplement). S49–S53. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026